Alx Oncology Holdings Inc (ALXO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8301 -0.0013 (-0.16%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8701 +0.0400 (+4.82%) 17:58 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 53,275 | 36,777 | 32,203 | 32,219 | 36,681 |
| Operating Income | -53,275 | -36,777 | -32,203 | -32,219 | -36,681 |
| Interest Expense | 391 | 372 | 387 | 231 | 2 |
| Other Income | 2,676 | 2,990 | 2,406 | 1,805 | 1,363 |
| Pre-tax Income | -50,990 | -34,159 | -30,184 | -30,645 | -35,320 |
| Net Income Continuous | -50,990 | -34,159 | -30,184 | -30,709 | -35,320 |
| Net Income | $-50,990 | $-34,159 | $-30,184 | $-30,709 | $-35,320 |
| EPS Basic Total Ops | -1.24 | -0.84 | -0.74 | -0.75 | -0.87 |
| EPS Basic Continuous Ops | -1.24 | -0.84 | -0.74 | -0.75 | -0.87 |
| EPS Diluted Total Ops | -1.24 | -0.84 | -0.74 | -0.75 | -0.87 |
| EPS Diluted Continuous Ops | -1.24 | -0.84 | -0.74 | -0.75 | -0.87 |
| EPS Diluted Before Non-Recurring Items | -1.24 | -0.84 | -0.58 | -0.75 | N/A |
| EBITDA(a) | $-54,845 | $-38,158 | $-33,043 | $-32,754 | $-36,945 |